In line, overexpression of CD98hc in intestinal epithelial cells leads to more severe colitis and colitis-associated cancer21, and the treatment of animals with nanoparticles carrying siRNA targeting CD98hc reduces colitis severity22. This evidence concerns the gene SLC3A2 and colitis.